Jacob Hunnicutt

Director, Epidemiology
Boehringer Ingelheim, United States

Disclosure information not submitted.

Presentation(s):

• Using probabilistic bias analysis to account for outcome misclassification of COVID-19 death in pharmacoepidemiologic studies

  Tuesday, August 27, 2024
  1:15 PM – 1:30 PM CEST